In the sweltering heat of a West African clinic, a mother cradles her vaccinated child. The baby sleeps soundly, unaware of the invisible enemy that once tore through communities. This is a rare moment of unguarded happiness in the long shadow of Ebola. And it is made possible by a UK-funded vaccine programme that is now expanding to reach the most vulnerable.
The sight is a stubborn reminder that progress is possible even in the darkest times. For years the region has been battered by outbreaks, poverty and a weak healthcare system. The vaccine, developed with British support, has become a lifeline. It has cut transmission rates and given health workers a fighting chance.
But let us not pretend this is a simple story of triumph. The UK’s contribution is a drop in the ocean of need. Funding remains precarious. The vaccine must be stored at minus 80 degrees Celsius, a logistical nightmare in areas without reliable electricity. And the workers on the front line are often underpaid and overstretched.
I spoke to Amina, a nurse who has lost colleagues to the virus. “Now I can sleep at night,” she said. “But we need more than vaccines. We need running water, decent pay, and a system that does not collapse with the next crisis.” Her words echo the frustrations of labour movements the world over. The joy of recovery is bittersweet when the structure around it is so fragile.
The expansion of the programme comes at a time when UK aid budgets are under scrutiny. Critics argue that the money should be spent at home on the NHS or on struggling families. That is a false choice. A virus that thrives in one corner of the world can travel anywhere. Investing in global health is investing in our own security.
But we must also be honest about the strings attached. Aid should not be a tool for corporate profit or political leverage. The real measure of success is whether a mother in a remote village can access a vaccine without bribes or long journeys. On that front, there is still much work to do.
For now, though, the moments of joy are real. A child laughing. A grandmother returning home. These are the dividends of a programme that puts science and solidarity first. The UK can be proud of its role, but it must not rest. The pandemic reminded us that germs do not respect borders. Neither should our compassion.
